<DOC>
	<DOC>NCT00131404</DOC>
	<brief_summary>A study to determine the safety and efficacy of an investigational drug in patients with obesity plus extension.</brief_summary>
	<brief_title>A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)</brief_title>
	<detailed_description />
	<criteria>Obese patients with a body mass index between 30 kg/m2 and 43 kg/m2, inclusive (BMI between 27 kg/m2 and 43 kg/m2, inclusive for those with obesityrelated comorbidities including hypertension, dyslipidemia, and sleep apnea Patients with serious or unstable current or past medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>